190 related articles for article (PubMed ID: 19339726)
1. From India to the world--a better way to prevent cervical cancer.
Schiffman M; Wacholder S
N Engl J Med; 2009 Apr; 360(14):1453-5. PubMed ID: 19339726
[No Abstract] [Full Text] [Related]
2. [Methods of cervical cancer screening and facing new problems in China].
Zhang WH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):881-4. PubMed ID: 19173985
[No Abstract] [Full Text] [Related]
3. Advances in cervical cancer screening and human papillomavirus vaccines.
Feeley C
J Br Menopause Soc; 2006 Mar; 12(1):19-23. PubMed ID: 16513018
[TBL] [Abstract][Full Text] [Related]
4. Experiences in the prevention and screening of cervical cancer within Thailand.
Kengsakul M; Laowahutanont P; Wilailak S
Int J Gynaecol Obstet; 2021 Jan; 152(1):48-52. PubMed ID: 33181003
[TBL] [Abstract][Full Text] [Related]
5. HPV primary screening for cervical cancer: more pain than protection.
Davey DD; Armenti CA
Diagn Cytopathol; 2000 Jun; 22(6):333-5. PubMed ID: 10820524
[No Abstract] [Full Text] [Related]
6. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
Kuhn L; Wang C; Tsai WY; Wright TC; Denny L
AIDS; 2010 Oct; 24(16):2553-61. PubMed ID: 20706107
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus-associated diseases in Israel--the controversy continues. Foreword.
Bornstein J; Shavit O
Vaccine; 2013 Nov; 31 Suppl 8():vii-x. PubMed ID: 24229722
[No Abstract] [Full Text] [Related]
8. [Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
Friedek DA; Ekiel AM; Martirosian G
Wiad Lek; 2007; 60(1-2):34-8. PubMed ID: 17607966
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model.
Usher C; Tilson L; Olsen J; Jepsen M; Walsh C; Barry M
Vaccine; 2008 Oct; 26(44):5654-61. PubMed ID: 18723068
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?
Saleem A; Tristram A; Fiander A; Hibbitts S
Minerva Med; 2009 Dec; 100(6):503-23. PubMed ID: 20010484
[TBL] [Abstract][Full Text] [Related]
11. The evolution of cost-effective screening and prevention of cervical carcinoma: implications of the 2006 consensus guidelines and human papillomavirus vaccination.
Monk BJ; Herzog TJ
Am J Obstet Gynecol; 2007 Oct; 197(4):337-9. PubMed ID: 17904955
[No Abstract] [Full Text] [Related]
12. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
13. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia.
Schiffman MH; Schatzkin A
Cancer Res; 1994 Apr; 54(7 Suppl):1944s-1947s. PubMed ID: 7794294
[TBL] [Abstract][Full Text] [Related]
14. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
Franco EL;
Cancer; 2023 Sep; 129(18):2765-2768. PubMed ID: 37347988
[No Abstract] [Full Text] [Related]
15. Forgotten implications of HPV positivity for the majority of females: a clinical perspective.
Tidy J
Cytopathology; 2002 Oct; 13(5):263-6. PubMed ID: 12421441
[No Abstract] [Full Text] [Related]
16. [Human papillomavirus and screening for cervical cancer: state of art and prospects].
Meijer CJ; Rozendaal L; Voorhorst FJ; Verheijen R; Helmerhorst TJ; Walboomers JM
Ned Tijdschr Geneeskd; 2000 Aug; 144(35):1675-9. PubMed ID: 10981235
[TBL] [Abstract][Full Text] [Related]
17. A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
Hammer A; Demarco M; Campos N; Befano B; Gravitt PE; Cheung L; Lorey TS; Poitras N; Kinney W; Wentzensen N; Castle PE; Schiffman M
Int J Cancer; 2020 Sep; 147(6):1612-1620. PubMed ID: 32141607
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.
Kim JJ; Wright TC; Goldie SJ
J Natl Cancer Inst; 2005 Jun; 97(12):888-95. PubMed ID: 15956650
[TBL] [Abstract][Full Text] [Related]
19. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer in low-income countries: A Bangladeshi perspective.
Hoque MR; Haque E; Karim MR
Int J Gynaecol Obstet; 2021 Jan; 152(1):19-25. PubMed ID: 32989750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
